The longitudinal and prospective study of morbidity revealed negative trends in the health status of children aged 0-14 years in the Russian Federation. Morbidity is growing across a significant number of various diseases, primarily neoplasms, congenital anomalies, diseases of the nervous, musculoskeletal systems and the connective tissue. There is a stable growth in the incidence of blood-clotting disorders, diabetes, obesity and contact dermatitis.

The article tells about the vital vitamin and mineral ingredients needed to maintain adequate physiological and neuro-psychic development of children. The innovative mineral and vitamin supplement Supradin® Kids is characterized and recommended for children to correct the existing deficiencies.

The article tells about the current situation with iodine deficiency in Russia, negative effects of iodine deficiency disorders on child and adolescent health, effective and safe methods of iodine prophylaxis.

Summary: The article reveals current data on the epidemiology of acute respiratory infections and antiviral defense mechanisms with regard to the anatomical and physiological characteristics of children's immune system and options for etiopathogenetic therapy. The focus is on the antiviral and immunomodulatory drug pranobex inosine (Isoprinosine), with data from literature on the use of inosine pranobex in children with respiratory infections. The efficacy and safety of inosine pranobex (Isopinosine) in pediatric practice is demonstrated.

Respiratory diseases in children are socially significant due to their high prevalence, the associated morbidity, disability and large sums of public money spent on providing patients with medicines and skilled medical care [1, 2].

The article tells about the basic mechanisms of inflammation, defines the scheme for rational care and symptomatic treatment of children with symptoms of pain and fever, antipyretic action of antipyretic analgesics. Optimal selection and rational use of antipyretic analgesics in pediatric practice is considered.

The article reflects current views on the problem of functional disorders of the pancreas in children. The discussion is focused on the complexity of diagnosis at nosological level; the most relevant clinical manifestations of pancreatopathy, from the viewpoint of the internist, are described; current diagnostic techniques are highlighted. Major group of drugs used for the correction of functional disorders of the pancreas are considered.

The article tells about the basic principles of local treatment of allergodermathosis in children and medicines used in the acute and remission stages; there is data on the efficacy and safety of the medicines.

Allergic rhinitis (AR) and bronchial asthma (BA) are certainly interrelated. Understanding the mechanisms of the relation could contribute to timely diagnosis and more effective treatment of both AP and AD in case of combination.

Introduction. Early diagnosis and adequate treatment of IDA in children today is undoubtedly a pressing issue, since iron is involved in many vital processes: reducing-oxidizing and enzymatic reactions, hematopoiesis and oxygen supply to organs and tissues. Iron deficiency may result in delayed growth and development in children, reduce performance and increase the incidence of acute respiratory infections. Early diagnosis, appropriate treatment and prevention of IDA are the main components of an integrated approach used today in the treatment of anemia to maintain the health of children.

The article summarizes data on the current classification, causes and methods for diagnosis of cardiomyopathy in children. Types of clinical symptoms, electrocardiographic, echocardiographic and biochemical changes are considered. The significance of results of additional tests for cardiomyopathy is highlighted.

Crouzon syndrome (craniofacial dysostosis) is an autosomal dominant disorder, a form of craniosynostosis syndrome; characterized by premature closure of cranial sutures, midfacial hypoplasia, lower mandibular prognathism, marked proptosis and strabismus [1]. The eponymous name of the syndrome comes from the name of Octave Crouzon, the French neurologist, who first described a craniofacial dysostosis in a mother and her daughter in 1912 [2].